Adial Pharmaceuticals Inc
Officers & Directors
Joseph M. Truluck Chief Financial Officer Principal Financial and Accounting Officer Cary Claiborne Chief Executive Officer and President Principal Executive Officer James W. Newman, Jr. Member of the Board of Directors J. Kermit Anderson Member of the Board of Directors Robertson H. Gilliland Member of the Board of Directors Kevin Schuyler Chairman of the Board of Directors CFA Tony Goodman Member of the Board of Directors ,
Adial Pharmaceuticals Inc currently has 6 employees.
News about Adial Pharmaceuticals Inc Key Personnel |
Overview of Financial PerformanceAdial Pharmaceuticals, Inc. (NASDAQ: ADIL), a pioneering biopharmaceutical firm based in Glen Allen, Virginia, recently published its financial results for the third quarter of 2024 and provided a comprehensive business update. The company operates in the healthcare sector, focusing on the development of therapies aimed at treating and preventing addiction and related disorders.During a one-year frame leading up to the second quarter of 2024, Adial recorded a cumulative net loss of $9 million. This financial strain has translated into a concerning negative return on investment (ROI) of -230.01%. Notably, within the healthcare industry, there were 503 other companies that dem...
|
Advancements in Alcohol Use Disorder Treatment: Adial Pharmaceuticals and the Evolving Landscape of Recovery DefinedIn a pivotal moment for the treatment of Alcohol Use Disorder (AUD), Adial Pharmaceuticals is at the forefront of innovation, aligning its research efforts with the National Institute on Alcohol Abuse and Alcoholism s (NIAAA) newly defined parameters for recovery. As the NIAAA shifts its focus to include non-abstinence solutions, Adial s investigational drug, AD04, stands as a beacon of hope for millions struggling with alcohol dependence. The company s recent developments not only validate the market potential for its pioneering therapy but also highlight a significant evolution in the underst...
|
|
